Vigour of CRISPR/Cas9 Gene Editing in Alzheimer’s Disease
Open Access
- 5 October 2018
- journal article
- Published by Heighten Science Publications Corporation in Journal of Neuroscience and Neurological Disorders
- Vol. 2 (2), 047-051
- https://doi.org/10.29328/journal.jnnd.1001014
Abstract
No abstract availableThis publication has 32 references indexed in Scilit:
- Genetics: Finding risk factorsNature, 2011
- Genetic Associations of Autopsy-Confirmed Vascular Dementia SubtypesDementia and Geriatric Cognitive Disorders, 2011
- CRISPR RNA maturation by trans-encoded small RNA and host factor RNase IIINature, 2011
- The culprit behind amyloid beta peptide related neurotoxicity in Alzheimer's disease: oligomer size or conformation?Alzheimer's Research & Therapy, 2010
- Clustered regularly interspaced short palindrome repeats (CRISPRs) have spacers of extrachromosomal originMicrobiology, 2005
- CRISPR elements in Yersinia pestis acquire new repeats by preferential uptake of bacteriophage DNA, and provide additional tools for evolutionary studiesMicrobiology, 2005
- Synaptic Targeting by Alzheimer's-Related Amyloid β OligomersJournal of Neuroscience, 2004
- Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis ConsortiumJAMA, 1997
- Human Apolipoprotein E4 Domain InteractionOnline Journal of Public Health Informatics, 1996
- Genetic Linkage Evidence for a Familial Alzheimer's Disease Locus on Chromosome 14Science, 1992